Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Marksans Pharma
NSEI:MARKSANS Community
1
Narratives
written by author
0
Comments
on narratives written by author
18
Fair Values set
on narratives written by author
Create a narrative
Marksans Pharma
Popular
Undervalued
Overvalued
Marksans Pharma
WA
Analyst Price Target
Consensus Narrative from 3 Analysts
Teva Pharma Facility And US Expansion To Strengthen Future Outlook
Key Takeaways Strategic growth in the U.S. market and facility expansion bolster revenue growth, earnings, and profit margins through enhanced capacity and market share. Improved product mix and operational efficiencies increase profitability by boosting gross and net margins through cost optimization.
View narrative
₹330.33
FV
30.9% undervalued
intrinsic discount
17.62%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
22 days ago
author updated this narrative
Your Valuation for
MARKSANS
Marksans Pharma
Your Fair Value
₹
Current Price
₹228.15
15.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
53b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹52.5b
Earnings ₹7.8b
Advanced
Set as Fair Value